Internal Medicine · Bakersfield, CA
NPI
1114937190
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9900 Stockdale Hwy Ste 107
Bakersfield, CA, 93311
Phone (661) 664-0600
Groups this clinician bills Medicare through
Medicare paid, 2024
$805K
29,994 services
Medicare patients, 2024
729
Average age 73
Drug cost, 2024
$3.8M
26,790 prescriptions
Company payments, 2025
$724
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pankaj Shukla was code 96372 (injection administration), 4,775 times for 546 patients. In total Pankaj Shukla billed 29,994 services in 54 codes, and Medicare paid $805K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96372 Injection Administration | Office | 4,775 | 546 | $12.30 | $59K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 4,750 | 337 | $0.75 | $3,560 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 4,316 | 270 | $0.52 | $2,251 |
| 99213 Office E&M - Established | Office | 3,116 | 634 | $77.10 | $240K |
| 99214 Office E&M - Established | Office | 2,659 | 658 | $104.35 | $277K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2,289 | 465 | $0.98 | $2,243 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,020 | 158 | $0.35 | $359 |
| 99458 E&M - Miscellaneous | Office | 490 | 36 | $34.47 | $17K |
| 82962 Clinical Chemistry | Office | 427 | 167 | $3.19 | $1,364 |
| G0008 Administration of influenza virus vaccine | Office | 314 | 312 | $32.99 | $10K |
| 90656 Vaccine Product | Office | 311 | 310 | $21.76 | $6,767 |
| 93306 Echocardiography (TTE/TEE) | Office | 251 | 249 | $172.30 | $43K |
| 99457 E&M - Miscellaneous | Office | 245 | 36 | $43.29 | $11K |
| 99454 E&M - Miscellaneous | Office | 243 | 36 | $43.47 | $11K |
| 93000 Electrocardiogram | Office | 215 | 197 | $11.08 | $2,382 |
By year: 2022 $675K for 34,314 services; 2023 $724K for 28,731 services; 2024 $805K for 29,994 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 427 | 167 | $3.19 | $1,364 |
| 87636 Infectious Agent Detection by DNA/RNA | 90 | 74 | $138.53 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Pankaj Shukla prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,540 prescriptions and refills. In total Pankaj Shukla wrote 26,790 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,540 | 4,077 | 476 | $11K |
| Losartan Potassium Generic | 1,158 | 3,112 | 344 | $8,688 |
| Levothyroxine Sodium Generic | 917 | 2,420 | 259 | $8,687 |
| Metformin Hcl Generic | 792 | 2,114 | 251 | $3,635 |
| Amlodipine Besylate Generic | 779 | 2,029 | 248 | $3,547 |
| Gabapentin Generic | 760 | 1,701 | 278 | $7,906 |
| Pantoprazole Sodium Generic | 646 | 1,610 | 255 | $6,435 |
| Januvia Sitagliptin Phosphate | 618 | 983 | 115 | $504K |
| Ozempic Semaglutide | 478 | 526 | 91 | $438K |
| Azithromycin Generic | 469 | 469 | 334 | $1,167 |
| Diclofenac Sodium Generic | 462 | 574 | 194 | $7,338 |
| Tamsulosin Hcl Generic | 427 | 1,100 | 137 | $4,112 |
| Jardiance Empagliflozin | 422 | 640 | 75 | $354K |
| Lisinopril Generic | 421 | 1,136 | 140 | $2,008 |
| Farxiga Dapagliflozin Propanediol | 413 | 682 | 95 | $362K |
Brand drugs: 5,435 claims; generic drugs: 20,906 claims; opioid claims: 302.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pankaj Shukla $724 ($724 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $150.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $150 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $103 |
| Novo Nordisk Inc NVO | 4 | $80.76 |
| GlaxoSmithKline, LLC. GSK | 4 | $71.92 |
| Mannkind Corporation MNKD | 2 | $59.27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57.19 |
| Ardelyx, Inc. ARDX | 3 | $53.55 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $39.36 |
| Abbott Laboratories ABT | 1 | $23.03 |
| Shield Therapeutics Inc STX.L | 1 | $18.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.